...
首页> 外文期刊>Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia >Local in situ fibrinolysis for recanalization of an occluded extracranial-intracranial bypass: Technical note
【24h】

Local in situ fibrinolysis for recanalization of an occluded extracranial-intracranial bypass: Technical note

机译:局部原位纤维蛋白溶解,用于再生胸腺颅内绕过的重新化:技术说明

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Extracranial-intracranial (EC-IC) bypass is a versatile technique to augment or preserve blood flow when treating cerebrovascular pathologies to prevent ischemic complications. Technical success and good patient outcomes rely on the successful establishment and maintenance of a patent bypass graft. Multiple modalities have been developed to confirm intraoperative graft patency. However, techniques and strategies to manage an occluded bypass are sparsely reported. The authors describe a novel technique for the in situ fibrinolysis utilizing recombinant tissue plasminogen activator (r-tPA) to recanalize an occluded EC-IC bypass following thrombus formation. This technique is feasible and effective in restoring long term EC-IC graft patency without requirement of additional vessel harvest or added ischemia time which may be tailored for use with other pharmacologic agents based on the acuity of an in-graft thrombosis. (C) 2019 Elsevier Ltd. All rights reserved.
机译:颅内颅内(EC-IC)旁路是一种多功能技术,用于在治疗脑血管病理学以防止缺血性并发症时增强或保持血液流动。 技术成功和良好的患者结果依赖于申请人旁路嫁接的成功建立和维护。 已经开发了多种方式来确认术中移植物通用。 然而,稀疏地报道了管理封闭旁路的技术和策略。 作者描述了利用重组组织纤溶酶原激活物(R-TPA)来重新血栓形成后闭塞EC-IC旁路的原位纤维蛋白溶解的新技术。 该技术在恢复长期EC-IC接枝通平面上是可行的,有效的,而不需要额外的血管收获或添加缺血时间,这可能根据接枝血栓形成的敏锐度定制以与其他药理学剂一起使用。 (c)2019年elestvier有限公司保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号